In a predictive
scoring algorithm based on hazard ratios for the risk
of cardiotoxicity from anthracycline therapy in
patients with metastatic breast cancer, over half of
the potential points in the algorithm were based on
cumulative anthracycline exposure dose. Other factors
increasing predicted risk were low performance
status, heavier weight and younger age